Landscapes / Companies
Mesoblast, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 6 in all
Trials
0 active
14 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cell therapy |
Approved | 28 Feb 2028Phase 3 trial completes | |||
| How it works | A cell therapy | ||||
| Next date | 28 Feb 2028 · Phase 3 trial completes | ||||
| Also tested for | GVHD - Graft-Versus-Host Disease | ||||
| Open drug page | |||||
About
- No active trial
- Mesenchymal Precursor Cells 12.5 M, Mesenchymal Precursor Cells 25 M, PROCHYMAL adult human mesenchymal stem cells, Prochymal- 8 Million cells/kg, Rexlemestrocel-L
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021